The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-06-24
DOI
10.3389/fonc.2019.00532
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term follow-up of de novo chronic phase chronic myelogenous leukemia patients on imatinib first-line
- (2018) Franck Emmanuel Nicolini et al. EXPERIMENTAL HEMATOLOGY
- A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial
- (2018) Riccardo Bomben et al. HAEMATOLOGICA
- Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment
- (2018) Elena Arrigoni et al. Stem Cells Translational Medicine
- A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial
- (2018) Riccardo Bomben et al. HAEMATOLOGICA
- Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission
- (2018) Monica Bocchia et al. Frontiers in Oncology
- Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1
- (2018) Joseph Schoepfer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report
- (2018) Nuno Cerveira et al. BMC CANCER
- The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia
- (2018) Sara Galimberti et al. Frontiers in Oncology
- Identification of WISP1 as a novel oncogene in glioblastoma
- (2017) Di Jing et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo
- (2017) H Zhou et al. LEUKEMIA
- Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition
- (2017) Bernd Groner et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
- (2017) Andreas Hochhaus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dysregulation of the DKK1 gene in pediatric B-cell acute lymphoblastic leukemia
- (2017) Sinem FIRTINA et al. Turkish Journal Of Medical Sciences
- The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia
- (2017) Sara Galimberti et al. Oncotarget
- ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview
- (2016) Elena Arrigoni et al. Expert Opinion on Drug Metabolism & Toxicology
- MicroRNA-375 suppresses human colorectal cancer metastasis by targeting Frizzled 8
- (2016) Lingling Xu et al. Oncotarget
- Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia
- (2015) Marialuisa Polillo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study
- (2015) Hakan Savlı et al. Turkish Journal of Hematology
- Polycomb genes are associated with response to imatinib in chronic myeloid leukemia
- (2015) Francesco Crea et al. Epigenomics
- Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role
- (2014) P-L Clermont et al. BRITISH JOURNAL OF CANCER
- The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy
- (2014) Elisabetta Rovida et al. CELL CYCLE
- The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia
- (2014) A Di Paolo et al. PHARMACOGENOMICS JOURNAL
- European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
- (2013) M. Baccarani et al. BLOOD
- Tumor-Initiating Cells and FZD8 Play a Major Role in Drug Resistance in Triple-Negative Breast Cancer
- (2013) S. Yin et al. MOLECULAR CANCER THERAPEUTICS
- Suppression of Survivin Induced by a BCR-ABL/JAK2/STAT3 Pathway Sensitizes Imatinib-Resistant CML Cells to Different Cytotoxic Drugs
- (2013) S. Stella et al. MOLECULAR CANCER THERAPEUTICS
- WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells
- (2012) G Yuan et al. ONCOGENE
- Wnt/Ca2+/NFAT Signaling Maintains Survival of Ph+ Leukemia Cells upon Inhibition of Bcr-Abl
- (2010) Mark A. Gregory et al. CANCER CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search